Bank of America’s Arcellx ACLX Stock Holding History

Bank of America’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,200	Closed	-$322K	–	8289
2024 Q4	$322K	Buy	+4,200	New	+$363K	﹤0.01%	5838

Other funds holding ACLX

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Bank of America's ACLX Position: Q1 2026 in Review

Bank of America increased its Arcellx (ACLX) stake by 5.7% in Q1 2026, buying an estimated $2.17M and bringing the position to 452,333 shares worth $51.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Bank of America first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

Bank of America held 452,333 shares of Arcellx worth $51.9M as of Q1 2026.
Bank of America bought 24,564 Arcellx shares in Q1 2026, an estimated $2.17M.
Arcellx made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1574 holding.
Bank of America first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.